Molecular mechanisms of bladder outlet obstruction in transgenic male mice overexpressing aromatase (Cyp19a1)

American Journal of Pathology

Volumn 178, Issue 3, 2011, Pages 1233-1244

  Lin, Wei ^a   Rahman, Nafis A ^b,c   Lin, Jian ^d,e   Zhang, Hua ^a   Gou, Kemian ^a   Yu, Wanpeng ^a   Zhu, Dahai ^f   Li, Ning ^a   Huhtaniemi, Ilpo ^b,g   Li, Xiangdong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF TURKU   (Finland)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d PEKING UNIVERSITY   (China)

^e PEKING UNIVERSITY FIRST HOSPITAL   (China)

^f INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; COLLAGEN TYPE 3; CYCLINE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UBIQUITIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER NECK STENOSIS; C57BL 6 MOUSE; INGUINAL HERNIA; KIDNEY FAILURE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSGENIC MOUSE; UREMIA;

EID: 79952766233     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.056     Document Type: Article

References (53)

1. Hald T: Urodynamics in benign prostatic hyperplasia: a survey. Prostate Suppl 1989, 2:69-77
2. Andersson KE: Storage and voiding symptoms: pathophysiologic aspects. Urology 2003, 62(5 Suppl 2):3-10
3. Andersson KE: LUTS treatment: future treatment options. Neurourol Urodyn 2007, 26(6 Suppl):934-947
4. Parsons JK: Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 2007, 178:395-401
5. Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S: Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol 2009, 56:14-20
6. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P: Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006, 50:1306-1314; discussion 1314-1305
7. Glasser DB, Carson C 3rd, Kang JH, Laumann EO: Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study. Int J Clin Pract 2007, 61:1294-1300 (Pubitemid 47052373)
8. Vallancien G, Pariente P: Treatment of lower urinary tract symptoms suggestive of benign prostatic obstruction in real life practice in France. Prostate Cancer Prostatic Dis 2001, 4:124-131 (Pubitemid 32633389)
9. Kay L, Stigsby B, Brasso K, Mortensen SO, Munkgaard S: Lower urinary tract symptoms - a population survey using the Danish Prostatic Symptom Score (DAN-PSS) questionnaire. Scand J Urol Nephrol 1999, 33:94-99 (Pubitemid 29349804)
10. Koskimäki J, Hakama M, Huhtala H, Tammela TL: Prevalence of lower urinary tract symptoms in Finnish men: a population-based study. Br J Urol 1998, 81:364-369 (Pubitemid 28316540)
11. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM: The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993, 150:85-89 (Pubitemid 23175978)
12. Krieg M, Weisser H, Tunn S: Androgen- und Estrogenstoffwechsel in der menschlichen benignen Prostatahyperplasie (BPH). [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)]. German. Verh Dtsch Ges Pathol 1993, 77:19-24
13. Schweikert HU, Tunn UW: Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia. Steroids 1987, 50:191-200
14. Schatzl G, Brössner C, Schmid S, Kugler W, Roehrich M, Treu T, Szalay A, Djavan B, Schmidbauer CP, Söregi S, Madersbacher S; The Prostate Study Group of the Austrian Society of Urology: Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. Urology 2000, 55:397-402 (Pubitemid 30110593)
15. Behre HM, Bohmeyer J, Nieschlag E: Prostate volume in testosterone- treated and untreated hypogonadal men in comparison to agematched normal controls. Clin Endocrinol (Oxf) 1994, 40:341-349 (Pubitemid 24194627)
16. Lahdes-Vasama TT, Koskimäki JE, Streng TK, Fisch RD, Nilson EA, Santti RS, Tammela TL: Urodynamic findings in men operated on for an undescended testicle. BJU Int 2003, 92:972-976 (Pubitemid 37548277)
17. Chun AL, Wein AJ, Harkaway R, Levin RM: Comparison of urinary bladder function in sexually mature and immature male and female rats. J Urol 1990, 143:1267-1271 (Pubitemid 20193104)
18. Kaufman JM, Vermeulen A: Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 1997, 11:289-309 (Pubitemid 27485029)
19. Morley JE, Patrick P, Perry HM 3rd: Evaluation of assays available to measure free testosterone. Metabolism 2002, 51:554-559 (Pubitemid 34516507)
20. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC: Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 1991, 145:405-409
21. Ekman P: The prostate as an endocrine organ: androgens and estrogens. Prostate Suppl 2000, 10:14-18
22. Kimm S, Mazar C, Salkini MW, Comiter CV: Solifenacin succinate prevents urodynamic and detrusor changes associated with bladder outlet obstruction-a mouse model (abstract). J Urol 2009, 181(4 Suppl):693
23. Lehtimäki J, Mäkel̈ AS, Viljamaa J, Yagi A, Paranko J, Santti R: Neonatal estrogenization of the male mouse results in urethral dysfunction. J Urol 1996, 156:2098-2103 (Pubitemid 26378061)
24. Afar DE, Vivanco I, Hubert RS, Kuo J, Chen E, Saffran DC, Raitano AB, Jakobovits A: Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Res 2001, 61:1686-1692 (Pubitemid 34292606)
25. Bianco JJ, Handelsman DJ, Pedersen JS, Risbridger GP: Direct response of the murine prostate gland and seminal vesicles to estradiol. Endocrinology 2002, 143:4922-4933 (Pubitemid 35397632)
26. Lemack GE, Zimmern PE, Vazquez D, Connell JD, Lin VK: Altered response to partial bladder outlet obstruction in mice lacking inducible nitric oxide synthase. J Urol 2000, 163:1981-1987 (Pubitemid 30366798)
27. Bernoulli J, Yatkin E, Konkol Y, Talvitie EM, Santti R, Streng T: Prostatic inflammation and obstructive voiding in the adult Noble rat: impact of the testosterone to estradiol ratio in serum. Prostate 2008, 68:1296-1306
28. Spearow JL, Doemeny P, Sera R, Leffler R, Barkley M: Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science 1999, 285:1259-1261 (Pubitemid 29398611)
29. Li X, Nokkala E, Yan W, Streng T, Saarinen N, Wärri A, Huhtaniemi I, Santti R, Mäkel̈ AS, Poutanen M: Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 2001, 142:2435-2442 (Pubitemid 32475760)
30. Li X, Wärri A, Mäkel̈ AS, Ahonen T, Streng T, Santti R, Poutanen M: Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology 2002, 143:4074-4083 (Pubitemid 35251782)
31. Li X, Strauss L, Mäkelä S, Streng T, Huhtaniemi I, Santti R, Poutanen M: Multiple structural and functional abnormalities in the p450 aromatase expressing transgenic male mice are ameliorated by a p450 aromatase inhibitor. Am J Pathol 2004, 164:1039-1048 (Pubitemid 38235485)
32. Kaufman MH, Robertson EJ, Handyside AH, Evans MJ: Establishment of pluripotential cell lines from haploid mouse embryos. J Embryol Exp Morphol 1983, 73:249-261 (Pubitemid 13160101)
33. Groutz A, Blaivas JG: Non-neurogenic female voiding dysfunction. Curr Opin Urol 2002, 12:311-316 (Pubitemid 34686772)
34. Huhtaniemi I, Nikula H, Rannikko S: Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue. J Clin Endocrinol Metab 1985, 61:698-704 (Pubitemid 16248094)
35. Li X, Strauss L, Kaatrasalo A, Mayerhofer A, Huhtaniemi I, Santti R, Mäkel̈ A S, Poutanen M: Transgenic mice expressing p450 aromatase as a model for male infertility associated with chronic inflammation in the testis. Endocrinology 2006, 147:1271-1277 (Pubitemid 43244360)
36. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER: A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630 (Pubitemid 40354745)
37. Monson FC, Sun L, Wein AJ, Levin RM: Hyperplasia in the rabbit bladder urothelium following partial outlet obstruction. Autoradiographic evidence. Mol Cell Biochem 1995, 152:167-173 (Pubitemid 26006139)
38. Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, Prins GS, Dodd JG, Duckworth ML, Matusik RJ: Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer [Corrected and republished from Lab Invest 1998;78(3):319-333]. Lab Invest 1998, 78(6):i-xv
39. Teng J, Wang ZY, Jarrard DF, Bjorling DE: Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Endocr Relat Cancer 2008, 15:351-364 (Pubitemid 351449753)
40. Uvelius B, Persson L, Mattiasson A: Smooth muscle cell hypertrophy and hyperplasia in the rat detrusor after short-time infravesical outflow obstruction. J Urol 1984, 131:173-176 (Pubitemid 14217030)
41. Oelke M, Höfner K, Wiese B, Grünewald V, Jonas U: Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men. World J Urol 2002, 19:443-452
42. Mäkinen S, Mäkelä S, Weihua Z, Warner M, Rosenlund B, Salmi S, Hovatta O, Gustafsson JA: Localization of oestrogen receptors alpha and beta in human testis. Mol Hum Reprod 2001, 7:497-503 (Pubitemid 32544552)
43. Bodker A, Balslev E, Juul BR, Stimpel H, Meyhoff HH, Hedlund H, Hedlund P, Iversen HG, Andersson KE: Estrogen receptors in the human male bladder, prostatic urethra, and prostate. An immunohistochemical and biochemical study. Scand J Urol Nephrol 1995, 29: 161-165
44. Schröder A, Pandita RK, Hedlund P, Warner M, Gustafsson JA, Andersson KE: Estrogen receptor subtypes and afferent signaling in the bladder. J Urol 2003, 170:1013-1016 (Pubitemid 36999623)
45. Renner O, Blanco-Aparicio C, Carnero A: Genetic modelling of the PTEN/AKT pathway in cancer research. Clin Transl Oncol 2008, 10:618-627
46. Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, Gurcan MN, Weinstein MB, Barsky SH, Yee L, Rosol TJ, Stromberg PC, Robinson ML, Pepin F, Hallett M, Park M, Ostrowski MC, Leone G: Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009, 461:1084-1091
47. Blanco A, Grana B, Fachal L, Santamarina M, Cameselle-Teijeiro J, Ruiz-Ponte C, Carracedo A, Vega A: Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN. Clin Genet 2010, 77:193-196
48. Marino M, Acconcia F, Trentalance A: Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol Biol Cell 2003, 14:2583-2591 (Pubitemid 36724344)
49. Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J, Maggi A, DiAugustine RP, Korach KS: Requirement of estrogen receptor- alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor crosstalk. J Biol Chem 2002, 277:8531-8537 (Pubitemid 34968316)
50. Stevenson K, Kucich U, Whitbeck C, Levin RM, Howard PS: Functional changes in bladder tissue from type III collagen-deficient mice. Mol Cell Biochem 2006, 283:107-114
51. Deveaud CM, Macarak EJ, Kucich U, Ewalt DH, Abrams WR, Howard PS: Molecular analysis of collagens in bladder fibrosis. J Urol 1998, 160:1518-1527 (Pubitemid 29480571)
52. Kaplan EP, Richier JC, Howard PS, Ewalt DH, Lin VK: Type III collagen messenger RNA is modulated in non-compliant human bladder tissue. J Urol 1997, 157:2366-2369 (Pubitemid 27208723)
53. Chavalmane AK, Comeglio P, Morelli A, Filippi S, Fibbi B, Vignozzi L, Sarchielli E, Marchetta M, Failli P, Sandner P, Saad F, Gacci M, Vannelli GB, Maggi M: Sex steroid receptors in male human bladder: expression and biological function. J Sex Med 2010, 8:2698-2713